Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the baseline sleep pattern disruption for patients
starting oral propranolol at the standard BID dosing regimen compared to the control
(timolol) group and to determine if there is a significant improvement in the sleep patterns
in infants taking oral propranolol on the TID dosing regimen versus the control (timolol)
group
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston